Metformin in oncology. Popular drug fights cancer.
Metformin is one of the most popular antidiabetic drugs. It is usually well-tolerated and widely used as a first line treatment in type II diabetes. However, there is more to metformin than meets the eye. The world of science held its breath when in 2010 the American Diabetes Association and American Cancer Society agreed, that taking metformin is clearly associated with a lower risk of cancer (1). For the last years various tests have been performed to warrant the theory. Does metformin prevent cancer in both diabetic and non-diabetic patients? Can the biguanide help those who already suffer from cancer? What are the possible mechanisms explaining the beneficial effects of metformin? We can find all the answers in a thorough review prepared by Bost et al., published in the January volume of “Current opinion in oncology” (2). Read full text »
Videos
Pictures
Documents















